The impact of Cardiovascular Autonomic Neuropathy in diabetes: Is it associated with left ventricular dysfunction?

Autonomic Neuroscience: Basic and Clinical

Volumn 132, Issue 1-2, 2007, Pages 1-7

  Debono, Miguel ^a   Cachia, Elaine ^b  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

^b ST LUKE S HOSPITAL   (Malta)

Author keywords

Cardiovascular Autonomic Neuropathy (CAN); Catecholamines; Diabetic Cardiomyopathy (DCM); Left ventricular dysfunction; Neuropeptidergic system

Indexed keywords

ADRENERGIC TRANSMISSION; AUTONOMIC NEUROPATHY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPATHETIC BLOCKING;

ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; CARDIOVASCULAR DISEASES; CORONARY VESSELS; DIABETIC NEUROPATHIES; HEART; HUMANS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847236595     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2006.11.003     Document Type: Review

References (47)

1. Adams K.F. New epidemiologic perspectives concerning mild-to-moderate heart failure. Am. J. Med. 110 (2001) 6S-12S
2. Ahluwalia A., and Cellek S. Regulation of the cardiovascular system by non-adrenergic non-cholinergic nerves. Curr. Opin. Nephrol. Hypertens. 6 (1997) 74-79
3. Bielawska A.E., Shapiro J.P., and Jiang L. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am. J. Pathol. 151 (1997) 1257-1263
4. Cellek S., Foxwell N.A., and Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 52 (2003) 2353-2362
5. Chow L.T., Chow S.S., Anderson R.H., and Gosling J.A. Autonomic innervation of the human cardiac conduction system: changes from infancy to senility-an immunohistochemical and histochemical analysis. Anat. Rec. 264 (2001) 169-182
6. Chiao H., and Caldwell R.W. The role of substance P in myocardial dysfunction during ischemia and reperfusion. Naunyn-Schmiedeberg's Arch Pharmacol. 353 (1996) 400-407
7. Communal C., Singh K., Pimentel D.R., and Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 98 (1998) 1329-1334
8. Di Carli M.F., Bianco-Batlles D., and Landa M.E. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100 (1999) 813-819
9. Dvoráková M., Kuncová J., Pfeil U., McGregor G.P., Svíglerová J., Slavíková J., and Kummer W. Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitonin gene-related peptide and altered expression of its receptor in rats. Neuroscience 134 (2005) 51-58
10. Esberg L.B., and Ren J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia 46 (2003) 1419-1427
11. Ewing D.J., Campbell I.W., and Clarke B.F. The natural history of diabetic autonomic neuropathy. Q. J. Med. 49 (1980) 95-108
12. Fang Z.Y., Yuda S., Anderson V., Short L., Case C., and Marwick T.H. Echocardiographic detection of early diabetic myocardial disease. J. Am. Coll. Cardiol. 41 (2003) 611-617
13. Fang Z.Y., Prins J., and Marwick T. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25 (2004) 543-567
14. Fava S., Azzopardi J., Muscat H.A., and Fenech F.F. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 16 (1993) 1615-1618
15. Fein F.S., and Sonnenblick E.H. Diabetic Cardiomyopathy. Prog. Cardiovasc. Dis. 27 (1985) 255-270
16. Hartmann F., Ziegler S., Nekolla S., Hadamitzky M., Seyfarth M., Richardt G., and Schwaiger M. Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: an analysis using carbon-11 hydroxyephedrine and positron emission tomography. Heart 81 (1999) 262-270
17. Ide T., Tsutsui H., and Hayashidani S. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ. Res. 88 (2001) 529-535
18. Joffe I., Travers K., Perreault-Micale C., Hampton T., Katz S., Morgan J., and Douglas P. Abnormal cardiac function in the streptozotocin-induced, non-insulin-dependent diabetic rat. Noninvasive assessment with Doppler echocardiography and contribution of the nitric oxide pathway. J. Am. Coll. Cardiol. 34 (1999) 2111-2119
19. Kontopoulos A.G., Athyros V.G., Didangelos T.P., Papageorgiou A.A., Avramidis M.J., Mayroudi M.C., and Karamitsos D.T. Effect of chronic Quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20 (1997) 355-361
20. Manzella D., Barbieri M., Rizzo M.R., Ragno E., Passariello N., Gambardella A., Marfella R., Giugliano D., and Paolisso G. Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J. Clin. Endocrinol. Metab. 86 (2001) 2769-2774
21. Maser, and Lenhard. Cardiovascular Autonomic neuropathy Due to diabetes mellitus: clinical manifestations, consequences, and treatment. J. Clin. Endocrinol. Metab. 90 (2005) 5896-5903
22. McEwan P.E., Gray G.A., Sherry L., Webb D.J., and Kenyon C.J. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation 98 (1998) 2765-2773
23. Nichols G.A., Gullion C.M., Koro C.E., Ephross S.A., and Brown J.B. The incidence of congestive heart failure in Type 2 diabetes: an update. Diabetes Care 27 (2004) 1879-1884
24. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., and Attali J.R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42 (1993) 1017-1025
25. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., Quaini E., Di Loreto C., Beltrami C.A., Kratjewski S., Reed J.C., and Anversa P. Apoptosis in the failing human heart. N. Engl. J. Med. 336 (1997) 1131-1141
26. Pfeifer M.A., Weinberg C.R., and Cook D.L. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care 7 (1984) 47-453
27. Poirier P., Bogaty P., Garneau C., Marois L., and Dumesnil J.G. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical Diabetic Cardiomyopathy. Diabetes Care 24 (2001) 5-10
28. Poirier P., Bogaty P., Philippon F., Garneau C., Fortin C., and Dumesnil J.G. Preclinical Diabetic Cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism 52 (2003) 1056-1061
29. Posner J., Ilya R., Wanderman K., and Weitzman S. Systolic time intervals in diabetes. Diabetologia 24 (1983) 249-252
30. Rathmann W., Ziegler D., and Jahnke M. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet. Med. 10 (1993) 820-824
31. Rosen R., Rump A.F., and Rosen P. The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats. Diabetologia 38 (1995) 509-517
32. Rosen P., Du X., and Tschope D. Role of oxygen derived free radicals for vascular dysfunction in the diabetic heart: prevention by a-tocopherol?. Mol. Cell. Biochem. 188 (1998) 103-111
33. Roy T.M., Peterson H.R., Snider H.L., and Cyrus J. Autonomic influence on cardiovascular performance in diabetic subjects. Am. J. Med. 87 (1989) 382-388
34. Roy T.M., Broadstone V.L., Peterson H.R., Snider H.L., Cyrus J., Fell R., Rothchild A.H., Samols E., and Pfeifer M.A. The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus. Diabetes Res. Clin. Pract. 10 (1990) 91-97
35. Salazar J., Rivas A., Rodriguez M., Felipe J., Garcia M.D., and Bone J. Left ventricular function determined by Doppler echocardiography in adolescents with type I (insulin-dependent) diabetes mellitus. Acta Cardiol. 49 (1994) 435-439
36. Sivieri R., Veglio M., Chinaglia A., Scaglione P., and Cavallo-Perin P. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. The Neuropathy Study Group of the Italian Society for the Study of Diabetes. Diabet. Med. 10 (1993) 920-924
37. Stevens M.J., Dayanikli F., Raffel D.M., Allman K.C., Sandford T., Feldman E.L., Wieland D.M., Corbett J., and Schwaiger M. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J. Am. Coll. Cardiol. 31 (1998) 1575-1584
38. Stewart B.W. Mechanisms of apoptosis: integration of genetic, biochemical and cellular indicators. J. Natl. Cancer Inst. 86 (1994) 1286-1296
39. Szabo C. PARP as a drug target for the therapy of diabetic cardiovascular dysfunction. Drug News Perspect. 15 (2002) 197-205
40. Uekita K., Tobise K., and Onodera S. Enhancement of the cardiac β-adrenergic system at an early diabetic state in spontaneously diabetic Chinese hamsters. Jpn. Circ. J. 61 (1997) 64-73
41. Vinik A.I., Maser R.E., Mitchell B.D., and Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26 (2003) 1553-1579
42. Willenheimer R.B., Erhardt L.R., Nilsson H., Lilja B., Juul-Moller S., and Sundkvist G. Parasympathetic neuropathy associated with left ventricular diastolic dysfunction in patients with insulin-dependent diabetes mellitus. Scand. Cardiovasc. J. 32 (1998) 17-22
43. Zabalgoitia M., Ismaeil M., Anderson L., and Maklady F. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am. J. Cardiol. 87 (2001) 320-323
44. Zhang X.M., Shen F., Xv Z.Y., Yan Z.Y., and Han S. Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats. Int. J. Cardiol. 105 (2005) 192-197
45. Ziegler D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev. 7 (1999) 300-315
46. Ziegler D., Schatz H., Conrad F., Gries F.A., Ulrich H., and Reichel G. Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Diabetes Care 20 (1997) 369-373
47. Zola B., Kahn J.K., Juni J.E., and Vinik A.I. Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease. J. Clin. Endocrinol. Metab. 63 (1986) 208-214